| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Chief Development Officer | Restricted Stock Unit | 77,000 | $381,851 | $4.96 | 31 Jan 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ZVRA | ZEVRA THERAPEUTICS, INC. | 31 Jan 2024 | 1 | $0 | 4 | Chief Development Officer | 02 Feb 2024, 20:14 |
| ZVRA | KEMPHARM, INC | 09 Jan 2023 | 1 | $0 | 4 | Chief Product Dev. Officer | 11 Jan 2023, 20:52 |
| ZVRA | KEMPHARM, INC | 06 Jan 2023 | 0 | $0 | 3 | Chief Product Dev. Officer | 10 Jan 2023, 20:19 |